Top mRNA therapeutics companies by Market Cap
Browse the largest mRNA therapeutics companies in the world ranked by their Market Capitalization. Global mRNA therapeutics Companies market cap is $411.96B.
19 Dec 2024, 12:25 UTC
Companies: 65
🇺🇸1 |  | $25.89 | -2.04% | 146.19B | -10.35% | Underperform S&P500 YTD Benchamark | 💊 Pharma | - |
🇺🇸2 |  | $447.50 | -4.63% | 115.32B | 10.49% | Underperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇯🇵3 |  | $26.47 | -0.05% | 41.53B | -0.46% | Underperform S&P500 YTD Benchamark | 💊 Pharma | - |
🇩🇪4 |  | $111.61 | -4.92% | 26.53B | 6.12% | Underperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇺🇸5 |  | $38.36 | -5.89% | 14.63B | -61.59% | Underperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇺🇸6 |  | $120.25 | -4.38% | 11.25B | 25.92% | Outperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇩🇰7 |  | $135.70 | -3.28% | 7.64B | 9.83% | Underperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇺🇸8 |  | $36.25 | -3.80% | 5.20B | -29.49% | Underperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇬🇧9 |  | $4.11 | 2.19% | 4.83B | 14117.39% | Outperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇺🇸10 |  | $16.00 | 0.00% | 3.30B | 0.00% | Underperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇨🇭11 |  | $41.06 | -8.00% | 3.26B | -33.60% | Underperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇨🇳12 |  | $1.80 | 0.46% | 2.89B | -44.32% | Underperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇯🇵13 |  | $16.85 | -0.40% | 2.19B | 76.15% | Outperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇺🇸14 |  | $20.36 | -8.58% | 2.17B | -33.25% | Underperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇺🇸15 |  | $26.45 | -7.45% | 2.16B | -1.86% | Underperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇨🇳16 |  | $6.01 | -5.66% | 1.92B | 124.52% | Outperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇧🇪17 |  | $26.60 | 0.78% | 1.75B | -31.17% | Underperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇨🇳18 |  | $4.52 | -0.96% | 1.60B | -47.18% | Underperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇺🇸19 |  | $23.73 | -5.23% | 1.44B | 12.09% | Underperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇺🇸20 |  | $26.04 | -0.61% | 1.42B | -33.71% | Underperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇺🇸21 |  | $12.02 | -8.45% | 1.08B | -60.00% | Underperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇺🇸22 |  | $9.81 | -5.22% | 999.85M | 1686.89% | Outperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇺🇸23 |  | $8.44 | -6.43% | 969.24M | 91.82% | Outperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇺🇸24 |  | $14.28 | -8.11% | 939.53M | 43.37% | Outperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇺🇸25 |  | $5.58 | -3.88% | 737.61M | -14.68% | Underperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇨🇳26 |  | $7.20 | -2.20% | 663.97M | 26.89% | Outperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇩🇪27 |  | $2.75 | -6.78% | 615.79M | -35.29% | Underperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇰🇷28 |  | $12.01 | 0.35% | 539.56M | 6.15% | Underperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇺🇸29 |  | $7.46 | -5.33% | 468.98M | 131.68% | Outperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇺🇸30 |  | $14.82 | -5.79% | 396.04M | -53.07% | Underperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇨🇳31 |  | $0.78 | -1.45% | 386.31M | -23.85% | Underperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇺🇸32 |  | $12.52 | -5.15% | 385.53M | 156.03% | Outperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇺🇸33 |  | $44.46 | -10.65% | 356.19M | -5.69% | Underperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇺🇸34 |  | $1.83 | -9.85% | 342.14M | 7.02% | Underperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇨🇳35 |  | $4.78 | -0.34% | 335.18M | -37.53% | Underperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇨🇳36 |  | $1.03 | 0.00% | 325.43M | -26.34% | Underperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇬🇧37 |  | $6.33 | -2.76% | 244.78M | -64.03% | Underperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇹🇼38 |  | $0.33 | -3.11% | 239.40M | -28.52% | Underperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇨🇳39 |  | $5.30 | -2.50% | 211.97M | -14.43% | Underperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇺🇸40 |  | $1.78 | -8.25% | 157.41M | -68.83% | Underperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇺🇸41 |  | $5.63 | -4.25% | 139.47M | 13.74% | Underperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇨🇦42 |  | $5.93 | -5.72% | 137.56M | -31.37% | Underperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇺🇸43 |  | $0.59 | -0.45% | 128.69M | 168.01% | Outperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇩🇪44 |  | $2.16 | -2.70% | 127.19M | 31.71% | Outperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇮🇱45 |  | $3.22 | 0.87% | 117.08M | 1851.10% | Outperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇺🇸46 |  | $1.35 | -11.51% | 109.85M | -86.55% | Underperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇰🇷47 |  | $1.40 | -3.33% | 109.39M | -28.27% | Underperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇫🇷48 |  | $1.49 | -7.46% | 106.69M | -48.61% | Underperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇹🇼49 |  | $2.05 | 0.00% | 101.94M | -0.15% | Underperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇺🇸50 |  | $4.06 | -5.58% | 96.68M | -40.12% | Underperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇯🇵51 |  | $0.97 | -1.96% | 68.24M | -21.05% | Underperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇺🇸52 |  | $0.17 | 4.29% | 55.01M | 25.00% | Outperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇺🇸53 |  | $0.46 | 0.00% | 40.60M | -89.94% | Underperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇵🇱54 |  | $2.37 | -1.93% | 39.82M | -49.78% | Underperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇰🇷55 |  | $3.26 | 4.53% | 37.38M | 61.99% | Outperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇺🇸56 |  | $3.16 | 4.64% | 32.80M | 209.80% | Outperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇺🇸57 |  | $2.68 | -14.38% | 29.48M | 482.61% | Outperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇦🇺58 |  | $0.06 | -5.00% | 17.67M | 28.38% | Outperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇺🇸59 |  | $2.51 | -7.04% | 11.48M | 243.84% | Outperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇫🇷60 |  | $1.79 | -0.57% | 10.88M | -63.19% | Underperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇺🇸61 |  | $0.67 | -3.04% | 8.26M | 45.43% | Outperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇬🇧62 |  | $0.05 | -10.47% | 6.25M | -46.90% | Underperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇺🇸63 |  | $0.27 | 3.85% | 1.46M | -85.56% | Underperform S&P500 YTD Benchamark | 🧬 Biotech | - |
